Ulrich A Walker

Summary

Affiliation: University of Basel
Country: Switzerland

Publications

  1. ncbi Multisegmental spondylitis due to Tropheryma whipplei: case report
    David Spoerl
    Department of Rheumatology, University of Basel, Felix Platter Spital, Basel, Switzerland
    Orphanet J Rare Dis 4:13. 2009
  2. ncbi Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005
    Alan Tyndall
    Rheumatology, University Hospital Basel, Felix Platter Spital, Burgfelderstrasse 101, Basel, CH 4012, Switzerland
    Arthritis Res Ther 9:301. 2007
  3. ncbi [Scleroderma and fibrosing diseases]
    U A Walker
    Rheumatologische Universitätsklinik, Universitat Basel, Burgfelderstrasse 101, Basel, Switzerland
    Z Rheumatol 68:312-9. 2009
  4. ncbi Imaging tools for the clinical assessment of idiopathic inflammatory myositis
    Ulrich A Walker
    Department of Rheumatology, Basel University, Basel, Switzerland
    Curr Opin Rheumatol 20:656-61. 2008
  5. ncbi Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database
    U A Walker
    Felix Platter Spital, Basel, Switzerland
    Ann Rheum Dis 68:856-62. 2009
  6. ncbi Rheumatic conditions in human immunodeficiency virus infection
    U A Walker
    Department of Rheumatology, Basel University, Basel, Switzerland
    Rheumatology (Oxford) 47:952-9. 2008
  7. ncbi Erectile dysfunction in systemic sclerosis
    U A Walker
    Department of Rheumatology, Basel University, Basel, Switzerland
    Ann Rheum Dis 68:1083-5. 2009
  8. ncbi Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database
    U A Walker
    Department of Rheumatology, Basle University, Felix Platter Spital, Burgfelderstrasse 101, Basel 4012, Switzerland
    Ann Rheum Dis 66:754-63. 2007
  9. ncbi 99mTechnetium pyrophosphate scintigraphy in the detection of skeletal muscle disease
    U A Walker
    Department of Rheumatology and Clinical Immunology, Albert Ludwigs University Medical School, Hugstetterstr 55, 79106 Freiburg, Germany
    Clin Rheumatol 26:1119-22. 2007
  10. ncbi Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled study
    G A McComsey
    Rainbow Babies and Children s Hospital, Cleveland, Ohio, USA
    Clin Infect Dis 46:1290-6. 2008

Detail Information

Publications15

  1. ncbi Multisegmental spondylitis due to Tropheryma whipplei: case report
    David Spoerl
    Department of Rheumatology, University of Basel, Felix Platter Spital, Basel, Switzerland
    Orphanet J Rare Dis 4:13. 2009
    ..In this clinical setting, routine PCR for Tropheryma whipplei from vertebral biopsies is recommended...
  2. ncbi Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005
    Alan Tyndall
    Rheumatology, University Hospital Basel, Felix Platter Spital, Burgfelderstrasse 101, Basel, CH 4012, Switzerland
    Arthritis Res Ther 9:301. 2007
    ..This review summarizes the findings of a 1-day meeting devoted to the subject with the aim of coordinating efforts...
  3. ncbi [Scleroderma and fibrosing diseases]
    U A Walker
    Rheumatologische Universitätsklinik, Universitat Basel, Burgfelderstrasse 101, Basel, Switzerland
    Z Rheumatol 68:312-9. 2009
    ..The diagnostic relevance of a histopathological diagnosis of fibrosing diseases varies and ranges from a disease-supporting to a disease-defining value...
  4. ncbi Imaging tools for the clinical assessment of idiopathic inflammatory myositis
    Ulrich A Walker
    Department of Rheumatology, Basel University, Basel, Switzerland
    Curr Opin Rheumatol 20:656-61. 2008
    ..To summarize advances in the imaging of idiopathic inflammatory myopathies...
  5. ncbi Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database
    U A Walker
    Felix Platter Spital, Basel, Switzerland
    Ann Rheum Dis 68:856-62. 2009
    ..The aetiology is unknown. Genetic and environmental susceptibility factors have been implicated. It is unknown whether disease presentation varies within Europe...
  6. ncbi Rheumatic conditions in human immunodeficiency virus infection
    U A Walker
    Department of Rheumatology, Basel University, Basel, Switzerland
    Rheumatology (Oxford) 47:952-9. 2008
    ..Thus, rheumatic diseases and asymptomatic immune phenomena remain prevalent in HIV-infected persons even after the widespread implementation of highly active anti-retroviral therapy...
  7. ncbi Erectile dysfunction in systemic sclerosis
    U A Walker
    Department of Rheumatology, Basel University, Basel, Switzerland
    Ann Rheum Dis 68:1083-5. 2009
    ..When intracavernous injections of prostaglandin E1 (alprostadil) are ineffective, the implantation of a penile prosthesis may be considered. Complex treatment options may require the involvement of urology...
  8. ncbi Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database
    U A Walker
    Department of Rheumatology, Basle University, Felix Platter Spital, Burgfelderstrasse 101, Basel 4012, Switzerland
    Ann Rheum Dis 66:754-63. 2007
    ..In order to better understand the vascular, immunological and fibrotic processes of SSc and to guide its treatment, the EULAR Scleroderma Trials And Research (EUSTAR) group was formed in June 2004...
  9. ncbi 99mTechnetium pyrophosphate scintigraphy in the detection of skeletal muscle disease
    U A Walker
    Department of Rheumatology and Clinical Immunology, Albert Ludwigs University Medical School, Hugstetterstr 55, 79106 Freiburg, Germany
    Clin Rheumatol 26:1119-22. 2007
    ....
  10. ncbi Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled study
    G A McComsey
    Rainbow Babies and Children s Hospital, Cleveland, Ohio, USA
    Clin Infect Dis 46:1290-6. 2008
    ..Lipoatrophy and mitochondrial toxicity have been linked to stavudine use, but it is unclear whether switching to a lower dose can reduce these toxicities while maintaining human immunodeficiency virus (HIV) suppression...
  11. ncbi Analgesic and disease modifying effects of interferential current in psoriatic arthritis
    U A Walker
    Department of Rheumatology and Clinical Immunology, Albert Ludwigs University, Medizinische Universitatsklinik, Hugstetterstr 55, 79106 Freiburg, Germany
    Rheumatol Int 26:904-7. 2006
    ..Bone scintigraphy showed a trend towards deterioration. New joints became inflamed within treated sites. Thus IFC has analgesic effects in PsA, but does not have a satisfactory disease modifying effect...
  12. ncbi [Lactic acidosis in HIV-patients--diagnosis and treatment]
    U A Walker
    Abt Rheumatologie und Klin Immunologie, Med Universitätsklinik Freiburg
    MMW Fortschr Med 146:65-7. 2004
    ..Uridine should be supplemented, a cocktail consisting of vitamins, L-carnitine and coenzyme Q10, may be given...
  13. ncbi Liquid chromatographic method for the determination of uridine in human serum
    M Zilly
    Department of Internal Medicine, Division of Infectious Diseases and Hepatology, Medizinische Poliklinik, University of Wuerzburg, Josef Schneider Strasse 2, D 97080 Wuerzburg, Germany
    J Chromatogr B Analyt Technol Biomed Life Sci 803:345-51. 2004
    ..It is suggested that a limited or inadequate uridine supply is at least in part responsible for the onset of such deterioration...
  14. ncbi [Inherited and acquired disorders of mitochondrial DNA]
    U A Walker
    Medizinische Universitätsklinik Abt Rheumatologie und Klinische Immunologie Hugstetterstr 55 D 79106 Freiburg
    Praxis (Bern 1994) 91:2129-38. 2002
    ..Therapy with vitamins, radical scavengers and L-carnitine is recommended, but of limited success...